Trials / Recruiting
RecruitingNCT07220824
A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
GUselkumab for the Treatment of PsA: Effectiveness Results by Ultrasound
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Janssen Research & Development, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess how well guselkumab works in improving symptoms of psoriatic arthritis (an inflammatory disease that affects the joints in participants with psoriasis, a skin condition that causes red, scaly patches) using muscoloskeletal ultrasound (MSUS) in a real-world setting.
Conditions
Timeline
- Start date
- 2025-12-04
- Primary completion
- 2027-07-31
- Completion
- 2027-09-30
- First posted
- 2025-10-24
- Last updated
- 2026-04-13
Locations
21 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT07220824. Inclusion in this directory is not an endorsement.